20 mg vial tirzepatide of Tirzepatide 60mg/3mL (20mg/mL) BPI : r/tirzepatidecompound

treat per standard of care and monitor until symptoms and signs resolve [see ADVERSE REACTIONS ]

The concept of a 'half dose' usually refers to beginning treatment at 1.25 mg (half of the standard 2.5 mg starting dose) or extending the time between dose increases

Concentration changes require new volume calculations and should be coordinated with your provider to ensure dosing accuracy

This gradual titration allows the digestive system to adapt, thereby reducing the likelihood of severe nausea

Observational data regarding thyroid cancer risk in humans using these medications have been mixed, and the human risk remains uncertain